Clinical Trials Browser

Brain Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Gastrointestinal Neoplasms, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Small Cell Lung Carcinoma

NCT00520975 2025-03-28

Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU

Phase 3 Terminated

96 enrolled 16 charts

Breast

Breast Neoplasms

NCT03936933 2025-02-17

Pharmacodynamic Study Goserelin 3.6mg Injection Administered Subcutaneously in Premenopausal Patients with Breast Cancer

Phase 3 Terminated

6 enrolled

Breast

Breast Neoplasms

NCT04395339 2024-08-01

GLORY

Phase 3 Terminated

51 enrolled

BreastCNS

Brain Neoplasms, Breast Neoplasms, Gangliosidoses, Radiation Injuries, Gangliosidosis, GM1, Cognitive Dysfunction

NCT05239663 2024-08-01

GM1 Prophylaxis for Post-chemotherapy Cognitive Impairment in Patients With Early Operable Breast Cancer

Phase 3 Terminated

76 enrolled

Breast

Chemotherapy-Related Cognitive Impairment, Breast Neoplasms

NCT05207514 2024-05-17

Compare the Efficacy and the Safety of Taxotere and Nanoxel M as Neoadjuvant Chemotherapy in Breast Cancer

Phase 3 Terminated

26 enrolled

Breast

Breast Neoplasms

NCT05065411 2024-02-26

VERU-024

Phase 3 Terminated

5 enrolled

Breast

Breast Neoplasms

NCT04869943 2024-01-26

ARTEST

Phase 3 Terminated

52 enrolled

Breast

Breast Neoplasms, Bulbo-Spinal Atrophy, X-Linked

NCT03786094 2023-11-01

FORTRESS

Phase 3 Terminated

432 enrolled 13 charts

Breast

Breast Neoplasms

NCT04385433 2023-08-24

PRAVAPREV-01

Phase 3 Terminated

15 enrolled

Breast

Breast Neoplasms

NCT03152929 2023-06-06

Paravertebral Block (PVC) Versus Pectoral Nerve Block (PEC)

Phase 3 Terminated

89 enrolled 14 charts

Breast

Agnosia, Breast Neoplasms

NCT04335006 2023-05-06

A Phase 3 Study Comparing Carelizumab Plus Nab-paclitaxel and Apatinib, Carelizumab Plus Nab-paclitaxel, and Nab-paclitaxel in Patients With Advanced Triple Negative Breast Cancer.

Phase 3 Terminated

80 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT00272987 2023-04-28

ErbB2 Over-expressing Metastatic Breast Cancer Study Using Paclitaxel, Trastuzumab, and Lapatinib

Phase 3 Terminated

63 enrolled 22 charts

Breast

Breast Neoplasms

NCT00004935 2023-04-18

Herceptin Followed by Chemotherapy in Treating Women With Metastatic Breast Cancer That Overexpresses HER2

Phase 3 Terminated

175 enrolled

Breast

Breast Neoplasms

NCT00543127 2023-03-10

Fulvestrant (Faslodex) + Anastrozole (Arimidex) vs Anastrozole

Phase 3 Terminated

870 enrolled 17 charts

Breast

Breast Neoplasms

NCT01905592 2022-11-15

BRAVO

Phase 3 Terminated

216 enrolled 19 charts

BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms

NCT02340221 2022-07-12

SANDPIPER

Phase 3 Terminated

631 enrolled 49 charts

Breast

Breast Neoplasms

NCT01067144 2022-05-05

Stanford Accelerated Recovery Trial (START)

Phase 3 Terminated

422 enrolled 12 charts

BreastThoracic

Breast Neoplasms, Lung Neoplasms, Pain

NCT01077154 2021-09-28

Study of Denosumab as Adjuvant Treatment for Women With High Risk Early Breast Cancer Receiving Neoadjuvant or Adjuvant Therapy (D-CARE)

Phase 3 Terminated

4,509 enrolled 25 charts

Breast

Breast Neoplasms

NCT00508274 2021-09-21

Lapatinib +Capecitabine Treatment for Advanced Metastatic Breast Cancer in Women From China

Phase 3 Terminated

52 enrolled 12 charts

Breast

Breast Neoplasms

NCT03326674 2021-07-30

CONTESSA

Phase 3 Terminated

685 enrolled

Breast

Breast Neoplasms, Neoplasm Metastasis

NCT03905343 2021-06-16

Ribociclib-endocrine Combination Therapy Versus Chemotherapy as 1st Line in Visceral mBC

Phase 3 Terminated

25 enrolled

Breast

Breast Neoplasms

NCT00296010 2021-02-23

CASA

Phase 3 Terminated

77 enrolled

Breast

Breast Neoplasms

NCT02730091 2021-02-01

VICTORIANE

Phase 3 Terminated

98 enrolled

Breast

Breast Neoplasms

NCT02137837 2021-01-28

S1222 Trial (Everolimus, Anastrozole and Fulvestrant) in Post-Menopausal Stage IV Breast Cancer

Phase 3 Terminated

37 enrolled 16 charts

Breast

Breast Neoplasms

NCT00625898 2020-09-10

BETH

Phase 3 Terminated

3,509 enrolled

Breast

Breast Neoplasms

NCT03050398 2020-05-28

A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib

Phase 3 Terminated

8 enrolled 4 charts

BreastEndocrine

Breast Neoplasms, Multiple Endocrine Neoplasia Type 1

NCT02532400 2020-03-11

COMPETE

Phase 3 Terminated

21 enrolled

Breast

Breast Neoplasms

NCT00908531 2019-04-29

REAL

Phase 3 Terminated

123 enrolled

Breast

Breast Neoplasms

NCT00130494 2019-04-16

Zoledronic Acid Administration to Metastatic Breast Cancer Patients With Non-symptomatic Bone Lesions

Phase 3 Terminated

97 enrolled

Breast

Breast Neoplasms, Neoplasm Metastasis

NCT01633060 2019-01-30

BELLE-3

Phase 3 Terminated

432 enrolled 20 charts

Breast

Breast Neoplasms, Neoplasm Metastasis, Hereditary Sensory and Autonomic Neuropathies

NCT00206440 2018-12-06

NEXIUM

Phase 3 Terminated

43 enrolled 5 charts

Breast

Breast Neoplasms, Nausea, Vomiting

NCT00193726 2018-09-20

Estrogen Priming to Increase the Efficacy of Adjuvant Chemotherapy in Operable Breast Cancer

Phase 3 Terminated

273 enrolled

Breast

Breast Neoplasms

NCT01035268 2018-08-22

GRATSEC

Phase 3 Terminated

196 enrolled

Breast

Breast Neoplasms

NCT02525211 2018-08-13

Continues Cicatricial Perfusion of Ropivacaine Versus Placebo After Mastectomy : Rehabilitation After Treatment

Phase 3 Terminated

59 enrolled

Breast

Breast Neoplasms

NCT03202446 2018-02-23

Randomized Clinical Trial Evaluating the Use of the Laser-Assisted Immunotherapy (LIT/inCVAX) in Advanced Breast Cancer

Phase 3 Terminated

18 enrolled

Breast

Breast Neoplasms

NCT01655992 2018-01-23

A Trial Comparing S1 Generic With Capecitabine in Metastatic Breast Cancer (MBC)

Phase 3 Terminated

386 enrolled

Breast

Breast Neoplasms

NCT00516269 2018-01-03

Trial of a Sustained Release Methylphenidate in the Treatment of Fatigue in Cancer Patients

Phase 3 Terminated

42 enrolled 8 charts

BreastGastrointestinal

Breast Neoplasms, Fatigue, Gastrointestinal Neoplasms

NCT00324324 2017-05-09

Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant

Phase 3 Terminated

240 enrolled

BreastCNSDermatologicGenitourinaryGynecologicLymphoidMyeloidOther hematologic neoplasmPlasma cell

Testicular Germ Cell Tumor, Pdgfra-Associated Chronic Eosinophilic Leukemia, Congenital Abnormalities, Carcinoma, Ovarian Epithelial, Blast Crisis, Breast Neoplasms, Burkitt Lymphoma, Hodgkin Disease, Infections, Leukemia, Leukemia, Hairy Cell, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Mycosis Fungoides, Myelodysplastic Syndromes, Myeloproliferative Disorders, Neuroblastoma, Ovarian Neoplasms, Sezary Syndrome, Testicular Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Neutrophilic, Chronic, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Gestational Trophoblastic Disease, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

NCT02144012 2017-03-07

A Study to Evaluate the Efficacy and Safety of Trastuzumab Emtansine Versus the Combination of Trastuzumab Plus Docetaxel in Patients With HER2-positive Breast Cancer

Phase 3 Terminated

49 enrolled 16 charts

Breast

Breast Neoplasms

NCT00912444 2016-11-22

NATT

Phase 3 Terminated

102 enrolled

Breast

Breast Neoplasms

NCT00066807 2016-10-28

PERCHE

Phase 3 Terminated

29 enrolled 6 charts

Breast

Breast Neoplasms

Clinical Trials

TSARINE

AXIL95

CLODIS

AMEERA-6

AMEERA-5

Fluorescence Imaging of Carcinoma During Breast Conserving Surgery

KATE3

eMonarcHER

Comparing Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in Patients With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic Radiosurgery

Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU

Pharmacodynamic Study Goserelin 3.6mg Injection Administered Subcutaneously in Premenopausal Patients with Breast Cancer

GLORY

GM1 Prophylaxis for Post-chemotherapy Cognitive Impairment in Patients With Early Operable Breast Cancer

Compare the Efficacy and the Safety of Taxotere and Nanoxel M as Neoadjuvant Chemotherapy in Breast Cancer

VERU-024

ARTEST

FORTRESS

PRAVAPREV-01

Paravertebral Block (PVC) Versus Pectoral Nerve Block (PEC)

A Phase 3 Study Comparing Carelizumab Plus Nab-paclitaxel and Apatinib, Carelizumab Plus Nab-paclitaxel, and Nab-paclitaxel in Patients With Advanced Triple Negative Breast Cancer.

ErbB2 Over-expressing Metastatic Breast Cancer Study Using Paclitaxel, Trastuzumab, and Lapatinib

Herceptin Followed by Chemotherapy in Treating Women With Metastatic Breast Cancer That Overexpresses HER2

Fulvestrant (Faslodex) + Anastrozole (Arimidex) vs Anastrozole

BRAVO

SANDPIPER

Stanford Accelerated Recovery Trial (START)

Study of Denosumab as Adjuvant Treatment for Women With High Risk Early Breast Cancer Receiving Neoadjuvant or Adjuvant Therapy (D-CARE)

Lapatinib +Capecitabine Treatment for Advanced Metastatic Breast Cancer in Women From China

CONTESSA

Ribociclib-endocrine Combination Therapy Versus Chemotherapy as 1st Line in Visceral mBC

CASA

VICTORIANE

S1222 Trial (Everolimus, Anastrozole and Fulvestrant) in Post-Menopausal Stage IV Breast Cancer

BETH

A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib

COMPETE

REAL

Zoledronic Acid Administration to Metastatic Breast Cancer Patients With Non-symptomatic Bone Lesions

BELLE-3

NEXIUM

Estrogen Priming to Increase the Efficacy of Adjuvant Chemotherapy in Operable Breast Cancer

GRATSEC

Continues Cicatricial Perfusion of Ropivacaine Versus Placebo After Mastectomy : Rehabilitation After Treatment

Randomized Clinical Trial Evaluating the Use of the Laser-Assisted Immunotherapy (LIT/inCVAX) in Advanced Breast Cancer

A Trial Comparing S1 Generic With Capecitabine in Metastatic Breast Cancer (MBC)

Trial of a Sustained Release Methylphenidate in the Treatment of Fatigue in Cancer Patients

Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant

A Study to Evaluate the Efficacy and Safety of Trastuzumab Emtansine Versus the Combination of Trastuzumab Plus Docetaxel in Patients With HER2-positive Breast Cancer

NATT

PERCHE